BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2965139)

  • 1. Prevention of exercise-induced bronchospasm in asthmatic children. Effect of aerosol and oral procaterol hydrochloride.
    Morooka T; Nishima S; Ota S
    J Asthma; 1987; 24(6):335-46. PubMed ID: 2965139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect.
    Mitsuhashi M; Kimura T; Tateno K; Morikawa A; Kuroume T
    J Asthma; 1985; 22(4):203-7. PubMed ID: 2931421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and inhaled salbutamol in the prevention of exercise-induced bronchospasm.
    Francis PW; Krastins IR; Levison H
    Pediatrics; 1980 Jul; 66(1):103-8. PubMed ID: 7402771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients.
    Taguchi O; Hida W; Nogami H; Inoue H; Takishima T
    Eur J Clin Pharmacol; 1988; 34(5):433-7. PubMed ID: 2974417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
    Boner AL; Sette L; Castellani C; Schiassi M
    J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new bronchodilating agent, procaterol, in preventing exercise-induced asthma.
    Ioli F; Donner CF; Fracchia C; Manini G; Patessio A; Spada EL; Vecchio C
    Int J Clin Pharmacol Res; 1986; 6(5):389-96. PubMed ID: 2946644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma.
    Kemp JP; Welch MJ; Meltzer EO; Orgel HA
    Ann Allergy; 1985 Oct; 55(4):588-92. PubMed ID: 2864890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of procaterol and salbutamol in single inhaled doses].
    Crespo Notario JA; Sobradillo Peña V; Garnacho López E; Ansola Zubiaurre PM; Mazo Echániz J
    Rev Clin Esp; 1989 Apr; 184(6):297-301. PubMed ID: 2526959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled procaterol versus salbutamol in bronchial asthma.
    Liippo K; Silvasti M; Tukiainen H
    Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
    Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
    Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of exercise-induced asthma by oral procaterol, a new beta 2-adrenergic drug.
    Del Bufalo C; Fasano L; Gunella G
    Respiration; 1984; 46(1):114-20. PubMed ID: 6238381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of albuterol and procaterol on exercise-induced asthma.
    Shapiro GG; Kemp JP; DeJong R; Chapko M; Bierman CW; Altman LC; Furukawa CT; Meltzer E; Orgel A; Pierson WE
    Ann Allergy; 1990 Oct; 65(4):273-6. PubMed ID: 2145791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.
    Boner AL; Zanotto CE; Piacentini G; Miglioranzi P; Richelli C; Sette L
    J Asthma; 1990; 27(1):21-30. PubMed ID: 2137815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of procaterol on arterial blood gas and pulmonary function in asthmatic children].
    Obata T; Masaki T; Iikura Y
    Arerugi; 1990 Dec; 39(12):1590-7. PubMed ID: 2151420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
    Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
    Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner.
    Kawai M; Sakai A; Takaori S; Hiura A; Sakata N; Nakashima M; Miyamoto T
    Methods Find Exp Clin Pharmacol; 2005; 27(6):385-9. PubMed ID: 16179955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
    Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
    J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.